These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34586520)

  • 1. ASO Author Reflections: The Feasibility of Preoperative FDG-Positive Lymph Nodes of Resectable Biliary Tract Cancers for Postoperative Prognosis.
    Kubo M; Kobayashi S
    Ann Surg Oncol; 2022 Feb; 29(2):945-946. PubMed ID: 34586520
    [No Abstract]   [Full Text] [Related]  

  • 2. Preoperative FDG-Positive Lymph Nodes Predict the Postoperative Prognosis in Resectable Biliary Tract Cancers.
    Kubo M; Kobayashi S; Gotoh K; Takayama H; Iwagami Y; Yamada D; Tomimaru Y; Akita H; Noda T; Kato H; Shimosegawa E; Doki Y; Eguchi H
    Ann Surg Oncol; 2022 Feb; 29(2):935-944. PubMed ID: 34586524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ASO Author Reflections: Evaluation of Lymph Nodes by FDG-PET for Esophageal Cancer.
    Hamai Y
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):664-665. PubMed ID: 31359280
    [No Abstract]   [Full Text] [Related]  

  • 4. Feasibility of (18)F-fluorodeoxyglucose positron-emission tomography for preoperative evaluation of biliary tract cancer.
    Yamada I; Ajiki T; Ueno K; Sawa H; Otsubo I; Yoshida Y; Shinzeki M; Toyama H; Matsumoto I; Fukumoto T; Nakao A; Kotani J; Ku Y
    Anticancer Res; 2012 Nov; 32(11):5105-10. PubMed ID: 23155288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biliary non-Hodgkin lymphoma detected by F-18 FDG PET/CT.
    Lam WW; Osmany S
    Clin Nucl Med; 2009 Nov; 34(11):791-2. PubMed ID: 19851177
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnostic value of FDG-PET for lymph node metastasis and outcome of surgery for biliary cancer.
    Kobayashi S; Nagano H; Hoshino H; Wada H; Marubashi S; Eguchi H; Takeda Y; Tanemura M; Kim T; Shimosegawa E; Hatazawa J; Doki Y; Mori M
    J Surg Oncol; 2011 Mar; 103(3):223-9. PubMed ID: 21140426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ASO Author Reflections: Adjuvant Chemoradiation in Resected Biliary Cancers-Insights and Implications.
    Dominguez DA; Melstrom LG
    Ann Surg Oncol; 2024 Aug; 31(8):4942-4943. PubMed ID: 38472671
    [No Abstract]   [Full Text] [Related]  

  • 8. ASO Author Reflections: Is It Important to Do Exercise Before Surgery for HPB Malignancy?
    Yokoyama Y
    Ann Surg Oncol; 2019 Jan; 26(1):273-274. PubMed ID: 30465225
    [No Abstract]   [Full Text] [Related]  

  • 9. The Value of Preoperative Positron Emission Tomography/Computed Tomography in Node-Negative Endometrial Cancer on Magnetic Resonance Imaging.
    Park JY; Lee JJ; Choi HJ; Song IH; Sung CO; Kim HO; Chae SY; Kim YT; Nam JH
    Ann Surg Oncol; 2017 Aug; 24(8):2303-2310. PubMed ID: 28550488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of ¹⁸F-fluorodeoxyglucose positron emission tomography positive lymph nodes on postoperative recurrence and survival in resectable thoracic esophageal squamous cell carcinoma.
    Yasuda T; Higuchi I; Yano M; Miyata H; Yamasaki M; Takiguchi S; Fujiwara Y; Hatazawa J; Doki Y
    Ann Surg Oncol; 2012 Feb; 19(2):652-60. PubMed ID: 21769466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high.
    Turkmen C; Sonmezoglu K; Toker A; Yilmazbayhan D; Dilege S; Halac M; Erelel M; Ece T; Mudun A
    Clin Nucl Med; 2007 Aug; 32(8):607-12. PubMed ID: 17667432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic importance of standardized uptake value on F-18 fluorodeoxyglucose-positron emission tomography in biliary tract carcinoma.
    Furukawa H; Ikuma H; Asakura K; Uesaka K
    J Surg Oncol; 2009 Nov; 100(6):494-9. PubMed ID: 19653260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of preoperative FDG-PET positive lymph nodes in lung cancer.
    Endoh H; Ichikawa A; Yamamoto R; Shiozawa S; Nishizawa N; Satoh Y; Oriuchi N
    Int J Clin Oncol; 2021 Jan; 26(1):87-94. PubMed ID: 32951076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of 18F-FDG PET-CT as a prognostic marker in advanced biliary tract cancer.
    Braghiroli MI; Mota JM; Duarte PS; Morita TO; Bariani GM; Nebuloni D; Buchpiguel CA; Hoff PM; Riechelmann RP
    Nucl Med Commun; 2018 Mar; 39(3):252-259. PubMed ID: 29381586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ASO Author Reflections: Adjuvant Chemoradiation for Patients with Resected Biliary Tract Cancers.
    Dee EC; Freret ME; Wo JY
    Ann Surg Oncol; 2020 Dec; 27(13):5173-5174. PubMed ID: 32748150
    [No Abstract]   [Full Text] [Related]  

  • 16. Does [18F] fluorodeoxyglucose-positron emission tomography/computed tomography have a role in cervical nodal staging for esophageal squamous cell carcinoma?
    Li B; Li N; Liu S; Li Y; Qian B; Zhang Y; He H; Chen X; Sun Y; Xiang J; Hu H; Chen H
    J Thorac Cardiovasc Surg; 2020 Aug; 160(2):544-550. PubMed ID: 31932053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ASO Author Reflections: Adjuvant Chemotherapy for Resected Biliary Tract Cancers-Does One Size Fit All?
    Rhodin KE; Lidsky ME
    Ann Surg Oncol; 2023 Aug; 30(8):4822-4823. PubMed ID: 37149546
    [No Abstract]   [Full Text] [Related]  

  • 18. Diagnostic and Prognostic Role of 18-FDG PET/CT in the Management of Resectable Biliary Tract Cancer.
    Ma KW; Cheung TT; She WH; Chok KSH; Chan ACY; Dai WC; Chiu WH; Lo CM
    World J Surg; 2018 Mar; 42(3):823-834. PubMed ID: 28905105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. F-18 FDG PET/CT scan in biliary cystadenocarcinoma.
    Takanami K; Kaneta T; Yamada S; Takahashi S
    Clin Nucl Med; 2009 Jul; 34(7):470-2. PubMed ID: 19542961
    [No Abstract]   [Full Text] [Related]  

  • 20. Lymph node staging of gastric cancer using (18)F-FDG PET: a comparison study with CT.
    Yun M; Lim JS; Noh SH; Hyung WJ; Cheong JH; Bong JK; Cho A; Lee JD
    J Nucl Med; 2005 Oct; 46(10):1582-8. PubMed ID: 16204706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.